1981
DOI: 10.1016/s0162-0134(00)80160-9
|View full text |Cite
|
Sign up to set email alerts
|

Three different cobalt complexes of bleomycin A2, B2, and Pepleomycin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

1982
1982
1996
1996

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…A number of laboratories prepared Co(III)-BLMs from Co(II), 02, and BLM; however, it was not until recently that the complex mixture of products produced were separated and partially characterized31, 124,127,130 (Scheme 11, Table XI). The Co(III)-BLMs are isolable with CM-Sephadex (ammonium formate elution) followed by reversed-phase HPLC.…”
Section: Co(iii)-blmmentioning
confidence: 99%
“…A number of laboratories prepared Co(III)-BLMs from Co(II), 02, and BLM; however, it was not until recently that the complex mixture of products produced were separated and partially characterized31, 124,127,130 (Scheme 11, Table XI). The Co(III)-BLMs are isolable with CM-Sephadex (ammonium formate elution) followed by reversed-phase HPLC.…”
Section: Co(iii)-blmmentioning
confidence: 99%
“…Aerobic oxidation of Co(II)-BLM (Sugiura 1980) results in at least three stable products (DeRiemer et al 1979;Vos et al 1981;Albertini and Garnier-Suillerot 1982;Chang and Meares 1983) which are referred to as the BROWN, GREEN, and ORANGE Co(III)-BLMs. The spectral properties of the BROWN Co(III)-BLM Meares 1983, 1984) and Co(III)-pseudotetrapeptide A (Dabrowiak and Tsukayama 1981, pseudotetrapeptide A (2_) is the hydrolysis product of BLM which lacks the sugar and bithiazole moieties of the drug) suggest that BLM most probably employs five nitrogen donor centers located in the primary and secondary amines, pyrimidine and imidazole rings, and the peptide moiety next to the pyrimidine ring (in the boxed area in I to bind cobalt in these species).…”
Section: H O~nh2mentioning
confidence: 99%
“…Aerobic oxidation of a solution containing Co(II) salts and BLM affords several Co(III) chelates of the drug that are often referred to as ORANGE, BROWN, and GREEN Co III −BLM. Spectroscopic studies have indicated that the cobalt(III) chelates of BLM most possibly employ five N donor centers located in the primary and secondary amines, the pyrimidine and the imidazole ring, and the peptide moiety adjacent to the pyrimidine. , The kinetically inert (low spin, d 6 system) Co III −BLMs bind to DNA quite strongly (10 6 −10 7 M -1 ) and do not cause any oxidative DNA damage like the Fe−BLMs. , However, Co III −BLMs cleave DNA when illuminated with UV 10,12 or visible light. Co III −BLMs photocleave DNA preferentially at pyrimidine residues located at the 3‘ side of guanines …”
Section: Introductionmentioning
confidence: 99%